Patent Assignment
Reel/Frame 062117/0155
Assignment of Assignor's Interest
Recorded: 2022-12-13
Pages: 26
Assignor
HORIZON PHARMA RHEUMATOLOGY LLC
Executed: 2020-03-31
Assignee
HORIZON THERAPEUTICS USA, INC.
1 HORIZON WAY, DEERFIELD, ILLINOIS, 60015
Covered Property
(1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Assignment of Assignor's Interest
May 27, 2021
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 056369/0172 →
Assignment of Assignor's Interest
May 27, 2021
From: SAVIENT PHARMACEUTICALS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 056408/0201 →
Change of Name
May 27, 2021
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 056408/0238 →
Change of Name
May 27, 2021
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 056408/0241 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →